{"id":58978,"date":"2026-02-23T13:07:35","date_gmt":"2026-02-23T17:07:35","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/market-retreats-as-new-15-global-tariffs-spark-trade-uncertainty-nvidia-earnings-loom\/58978\/"},"modified":"2026-02-23T13:07:35","modified_gmt":"2026-02-23T17:07:35","slug":"market-retreats-as-new-15-global-tariffs-spark-trade-uncertainty-nvidia-earnings-loom","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/market-retreats-as-new-15-global-tariffs-spark-trade-uncertainty-nvidia-earnings-loom\/58978\/","title":{"rendered":"Market Retreats as New 15% Global Tariffs Spark Trade Uncertainty; Nvidia Earnings Loom"},"content":{"rendered":"

U.S. equity markets are experiencing a volatile start to the week this Monday, February 23rd, 2026, as investors grapple with a rapid escalation in trade policy tensions. Midday trading shows a definitive shift toward a "risk-off" sentiment, with major indexes retreating from recent highs. The primary catalyst for today\u2019s downward momentum is the White House\u2019s announcement of a new 15% global tariff on all imports, a move that follows a landmark Supreme Court ruling on Friday which had briefly struck down previous "reciprocal" trade measures.<\/p>\n

Index Performance and Midday Momentum<\/h2>\n

As of midday, the major market benchmarks are firmly in the red. The S&P 500<\/a> (SPX<\/a>) has fallen approximately 0.8%, trading near the 6,835 level. The Dow Jones<\/a> Industrial Average (DJI<\/a>) is the day's laggard, shedding over 750 points, or 1.3%, to hover around 48,857. Meanwhile, the tech-heavy Nasdaq Composite (COMP<\/a>) is down 0.9%, currently positioned at 22,596.<\/p>\n

Market momentum has been characterized by a sharp morning sell-off followed by a cautious, range-bound consolidation during the lunch hour. The CBOE Volatility Index (VIX), often referred to as the market's "fear gauge," has spiked as traders weigh the potential for renewed inflationary pressures stemming from the 15% import duties.<\/p>\n

Tariff Turmoil and Economic Outlook<\/h2>\n

The sudden shift in trade policy has overshadowed recent optimism. While the Supreme Court initially ruled that the executive branch lacked the authority to impose certain "reciprocal" taxes under the International Emergency Economic Powers Act (IEEPA), the administration responded on Saturday by invoking Section 122 to implement a 15% temporary tariff.<\/p>\n

Economists warn that these measures could complicate the Federal Reserve's path. Currently, the core PCE price index\u2014the Fed's preferred inflation gauge\u2014is running at a 3% annual rate. Persistent inflation and new trade costs are keeping the "higher for longer" interest rate narrative alive. Investors are looking ahead to the January Producer Price Index (PPI) report later this week for further clues on wholesale pricing trends.<\/p>\n

Major Stock News and Corporate Developments<\/h2>\n

The corporate landscape is dominated by a massive sell-off in the pharmaceutical sector and anticipation for high-stakes tech earnings.<\/p>\n

Novo Nordisk (NVO<\/a>) shares have plummeted 15.9% today after the Danish drugmaker revealed that a trial for its experimental weight-loss drug, CagriSema, showed results that lagged behind its primary rival. This has provided a relative boost to Eli Lilly (LLY<\/a>), which continues to dominate the obesity-treatment market.<\/p>\n

In the technology sector, all eyes are on Nvidia<\/a> (NVDA<\/a>). Despite the broader market slump, Nvidia<\/a> is trading slightly higher as investors position themselves ahead of its critical Q4 earnings report scheduled for Wednesday. As the world\u2019s largest company by market cap, Nvidia<\/a>\u2019s outlook on AI infrastructure spending is viewed as the ultimate bellwether for the current bull cycle.<\/p>\n

Other notable movers include:<\/p>\n